Showing 1-10 of about 1435 articles.
Sanofi
Dépôt du Document d’Enregistrement Universel 2020, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Paris (France) – Le 4 mars 2021 – Sanofi annonce avoir déposé son Document...
Sanofi
Filing of the 2020 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report PARIS, France – March 4, 2021 - Sanofi announces today the filing of its Form...
Sanofi
FDA accepts Dupixent® (dupilumab) for review in children with moderate-to-severe asthma Submission supported by data demonstrating Dupixent significantly reduced severe asthma attacks and is the...
Sanofi
La FDA accepte d’examiner Dupixent® (dupilumab) dans le traitement de l’asthme modéré à sévère de l’enfant La soumission prend appui sur des données ayant démontré que Dupixent réduit...
Sanofi
Le Conseil d’administration de Sanofi propose la nomination de Christian Brandts et Barbara Lavernos aux postes d’administrateurs Paris (France) – Le 3 mars 2021 - Lors de sa séance du 3 mars...
Sanofi
Sanofi’s Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members Paris, France – March 3, 2021 – At its meeting on March 3, 2021, Sanofi’s Board of...
Sanofi
FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50% Libtayo was superior in extending overall survival...
Sanofi
La FDA approuve Libtayo® (cemiplimab-rwlc)...
Sanofi
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
Showing 1-10 of about 1435 articles.
